| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cue Biopharma, Inc. | CHIEF EXECUTIVE OFFICER, Director | Stock Option (right to buy) | 1,875,000 | 29 Sep 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CUE | Cue Biopharma, Inc. | 29 Sep 2025 | 1 | $0 | 4 | CHIEF EXECUTIVE OFFICER, Director | 02 Oct 2025, 20:13 |
| CUE | Cue Biopharma, Inc. | 29 Sep 2025 | 0 | $0 | 3 | CHIEF EXECUTIVE OFFICER, Director | 02 Oct 2025, 20:13 |